#SYNC Syncona - UK closed-end trust invests in biotech with focus on cell & gene therapies. Discount to NAV. Decent track record. One to watch for diversified biotech exposure?
Share price returned to levels that brought 3 insider buys from Feb to Apr 2022
Syncona Limited - 160p
TIKR PROFILE
https://app.tikr.com/stock/about?cid=222383992&tid=222550964&ref=lnv9v8
DESCRIPTION - Syncona is a UK listed (closed-end) investment trust that invests into biotech companies with a particular focus on cell therapies, gene therapies, biologics and small molecules. Founded in 2012, it has a 10 year track record of success…